| Literature DB >> 23958173 |
Juliet Nabyonga Orem1, Bruno Marchal, DavidKaawa Mafigiri, Freddie Ssengooba, Jean Macq, Valeria Campos Da Silveira, Bart Criel.
Abstract
BACKGROUND: Stakeholder roles in the application of evidence are influenced by context, the nature of the evidence, the policy development process, and stakeholder interactions. Past research has highlighted the role of stakeholders in knowledge translation (KT) without paying adequate attention to the peculiarities of low-income countries. Here we identify the roles, relations, and interactions among the key stakeholders involved in KT in Uganda and the challenges that they face.Entities:
Mesh:
Year: 2013 PMID: 23958173 PMCID: PMC3751734 DOI: 10.1186/1472-6963-13-324
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
A summary of the roles played by various stakeholders in KT
| CSOs | Representing and advocating for the communities they serve, mobilizing resources for undertaking research, undertaking research, disseminating and facilitating the implementation of decisions based on evidence |
| Communities | Involvement in setting the research agenda, demanding the application of evidence |
| Media | Dissemination of information and social mobilization |
| Policy makers | Identifying knowledge gaps, commissioning and guiding research processes, applying evidence in decision-making, establishing institutional platforms for KT |
| Politicians | Advocacy, setting research priorities, disseminating evidence, mobilizing communities |
| Researchers | Generating evidence |
| Donors | Providing funding for research, KT activities, and implementation of research findings |
| Knowledge brokers | Disseminating evidence |
| Formal and informal networks and professional bodies | Generating and disseminating evidence |
Key informant respondents
| 9 | 4 | three for more than 7 years and one for 3 years | ||
| | | | ||
| District level | 1 | 1 | for over 7 years | |
| Facility-based CSOs | 2 | 2 | at least 6 years | |
| Non-facility-based CSOs | 2 | 2 | 6 years and 3 years | |
| Private for-profit providers | 1 | 1 | 2 years | |
| | | | ||
| Bilateral | 4 | 2 | Four for 6 years, one for 6 months, and one for 2 years | |
| Multilateral | 3 | 3 | For at least 7 years | |
| | | | | |
| | Public (from the School of Public Health) | 0 | 1 | over 14 years |
| | Private (from a private research group) | 0 | 1 | 2 years |
| | 0 | 2 | at least 10 years | |
| | 0 | 2 | 2 years, but previously worked with the health sector for over 15 years | |
Researchers, journalists and parliamentarians are not members of HPAC.
Identified positive and negative roles for various stakeholders
| CSOs | Using research results (10) | May de-campaign evidence if they are not convinced (2) | Lack of capacity, weak internal organization, lack of independence |
| Advocating with policy makers to implement evidence (8) | |||
| If not given proper information, may cause confusion (1) | |||
| Mobilizing communities (7) | |||
| Disseminating research (2) | |||
| Undertaking research (2) | |||
| Liaising with the media (1) | |||
| Generating research topics (1) | |||
| Communities | Can demand that evidence be implemented or demand that a policy be developed (6) | Can be disruptive if results do consider community-contextual issues (1) | Currently not able to engage in research policy processes |
| Contributing to development of the research agenda (6) | |||
| Can participate in research (1) | |||
| Media | Disseminating research results (15) | Misrepresenting evidence (5) | Not well organized and are communicating to a public that is not strong enough to respond |
| Putting forward community views (4) | De-campaigning implementation of evidence if they are not convinced (3) | ||
| Advocating for implementing evidence (1) | |||
| Policy makers | Using evidence in developing policies and implementation (12) | If evidence is not in their favor, can de-campaign it or misrepresent results (2) | Inclined to serve political interests |
| May remain unconcerned about available evidence and play a passive role (1) | |||
| | |||
| Establishing structures that can improve uptake of research ( | |||
| Providing stewardship (5) | |||
| Participating in research (1) | |||
| Parliamentarians/politicians | Demanding implementation of evidence (8) | Focus may differ; if they see that the available evidence does not favor their objectives and may lead to the loss of votes, they will not support the evidence. If they stand to benefit, they will support the evidence (4) | Difference in objectives; technical objectives may differ from political objectives |
| Advocating for funding to implement recommendations (4) | |||
| Mobilizing and disseminating evidence to their communities (4) | |||
| Researchers | Undertaking research (14) | Corruption affects the research community to the extent that they may even provide misleading results (1) | Balancing satisfying academic interest and community needs |
| Research users (1) | |||
| Donors | Providing funding for research (16) | May carry out research that does not focus on local needs (3) | Availability of institutionalized platforms for setting research agendas and engaging in KT under strong MoH leadership |
| Providing funding for implementation (9) | |||
| At times they work toward fulfilling agency agendas (2) | |||
| Undertaking research activities (5) | |||
| May refuse to fund implementation of certain recommendations, for whatever reasons (1) | |||
| Encouraging the development of evidence-based polices (2) | |||
| WHO provides global evidence that guides policy development in countries (2) | |||
| Can make financial commitments to support implementation of evidence but fail to meet them (1) | |||
| Implementing research recommendations (1) | |||
| Influencing the research agenda (1) | |||
| Failure to contextualize global knowledge (1) | |||
| May bring in global knowledge (1) | |||
| Private health providers | Using evidence to make investment decisions (1) | Weak internal organization |